Hepatocellular carcinoma (HCC) is an aggressive malignancy with limited effective
treatments and ranks as the second most lethal tumor. Immunotherapy has brought great …

Abnormal expression of programmed death-ligand 1 (PD-L1) on cancer cells contributes to
immune escape in hepatocellular carcinoma (HCC). Paeoniflorin has been shown to inhibit …

Currently available therapies for hepatocellular carcinoma (HCC), with a high morbidity and
high mortality, are only marginally effective and with sharp adverse side effects, which …

Hepatocellular carcinoma (HCC) is the most frequent primary liver malignancy globally and
the third leading cause of cancer-related death. Chemotherapy is one of the main methods …

Pancreatic cancer has remained a major cause of cancer-related deaths. A hallmark of
pancreatic cancer is extensive stromal reactions, resulting in a unique tumor …

Aim The aim of this study is to explain effect and mechanism of Sophoridine to suppress
Hepatocellular carcinoma in vitro and vivo. Methods In vitro experiment, the HepG2 cells …

Background Interleukin-6 (IL-6) is a multifunctional cytokine, which is involved in the
regulation of differentiation and growth of certain types of tumor cells. Constitutive activation …

Although plumbagin, a natural naphthoquinone, has exhibited antiproliferative activity in
numerous types of cancer, its anticancer potential in esophageal squamous cell carcinoma …

Hepatocellular carcinoma (HCC) is the most common liver or hepatic cancer, accounting for
80% of all cases. The majority of this cancer mortality is due to metastases, rather than …

Hepatocellular carcinoma (HCC) is difficult to treat, and is the second leading cause of
cancer-related death worldwide. This study aimed to examine whether combination of …